Aimmune Therapeutics
oral desensitization immunotherapy
- B2C
About Aimmune Therapeutics
development and commercialization of oral therapies to desensitize patients and protect against life-threatening food allergy reactions
Key facts
- Industry
- Biotechnology
- Company size
- 51–250 employees
- Headquarters
- Brisbane, California, United States
- Founded
- 2011
- Revenue
- $13M – $103MTamtam estimate
- Website
- aimmune.com
Aimmune Therapeutics at a glance
Aimmune Therapeutics is a B2C company in the Biotechnology industry, headquartered in Brisbane, California, United States.
Aimmune Therapeutics was founded in 2011.
Aimmune Therapeutics has 51–250 employees.
Aimmune Therapeutics's revenue is $13M – $103M (Tamtam estimate).
Selling to companies like Aimmune Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies